Regulations restricting the sale and supply of gonadotrophin-releasing hormone analogues
As previously announced, regulations have come into force to restrict the prescribing and supply of puberty suppressing hormones / gonadotrophin releasing hormone (GnRH) analogues to children and young people under 18 for the purposes of gender dysphoria / gender incongruence. During the period of the emergency ban (currently from 3 June to 3 September 2024), [...]
The post Regulations restricting the sale and supply of gonadotrophin-releasing hormone analogues appeared first on Community Pharmacy England.
Recent Comments